How to Order ? Simple.
-
1.
Select Treatment
Choose from our treatment options or speak to the in-store pharmacist for advice
-
2.
Complete Medical Questionnaire
Complete our free online medical consultation to be reviewed by our Clinical Team
-
3.
Collect Medication from Local Pharmacy
We will notify you when your medication is ready for collection
Advice for Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia (BPH), also known as benign prostate enlargement (BPE), is a common and non-cancerous condition where the prostate gland grows larger. It primarily affects older men and individuals with a prostate, typically becoming more prevalent after age 50.
What is the Prostate? The prostate is a walnut-sized gland located below the bladder and in front of the rectum, surrounding the urethra (the tube that carries urine from the bladder out of the body). Its main function is to produce fluid that mixes with sperm to form semen.
Causes: The exact cause of BPH is not fully understood, but it's strongly linked to hormonal changes that occur as men age. One prominent theory suggests that an increase in dihydrotestosterone (DHT), a male hormone, or an imbalance between testosterone and estrogen levels, may stimulate prostate cell growth.
Risk factors for BPH include:
Age: The risk significantly increases with age.
Family History: A genetic predisposition can increase the likelihood of developing BPH.
Diabetes and Heart Disease: Some studies suggest a link between these conditions and BPH.
Obesity and Metabolic Syndrome: These are also considered risk factors.
Symptoms: As the prostate enlarges, it can press on the urethra, obstructing urine flow from the bladder. This leads to a range of "lower urinary tract symptoms" (LUTS), which can vary in severity. Common symptoms include:
Urinary Frequency: Needing to urinate often, especially at night (nocturia).
Urgency: A sudden, strong need to urinate, sometimes leading to incontinence.
Difficulty Starting Urination (Hesitancy): Trouble initiating the urine stream.
Weak or Intermittent Urine Stream: A diminished force of urine flow or a stream that stops and starts.
Straining: Needing to push or strain to urinate.
Incomplete Emptying: Feeling like the bladder isn't fully empty even after urination.
Dribbling: Leakage of urine after finishing urination.
While BPH is not cancer and does not increase the risk of prostate cancer, its symptoms can significantly impact quality of life. In severe cases, BPH can lead to complications such as urinary tract infections, bladder stones, bladder or kidney damage, and acute urinary retention (complete inability to urinate).
Benign Prostatic Hyperplasia (BPH) is a complex condition, and its exact cause is not fully understood, but it is strongly linked to a combination of factors, primarily aging and hormonal changes in men.
Here's a breakdown of the key contributing factors:
1. Hormonal Changes:
Dihydrotestosterone (DHT): This is the most widely accepted primary hormonal factor.
As men age, the enzyme 5-alpha reductase converts testosterone into DHT in the prostate. DHT is a potent androgen that stimulates the growth of prostate cells. While DHT levels in the blood may not necessarily be higher in men with BPH, the prostate's sensitivity and response to DHT are believed to play a significant role in its enlargement. Estrogen: As men age, testosterone levels tend to decrease, while estrogen levels (produced in smaller amounts in men) may remain relatively stable or even increase proportionally.
This shift in the estrogen-to-androgen ratio is thought to contribute to prostate growth. Estrogens can also directly and indirectly affect prostate cell growth and differentiation. Imbalance between Cell Growth and Cell Death (Apoptosis): BPH results from a loss of the normal balance (homeostasis) in the prostate, where the rate of cell proliferation (growth) outpaces the rate of apoptosis (programmed cell death).
Hormonal influences are believed to disrupt this balance.
2. Aging:
Age is the most significant and consistent risk factor for BPH.
The prevalence of BPH increases dramatically with each decade of life. While microscopic evidence of BPH can be found in many men by their 40s, symptomatic BPH typically becomes common after age 50, with rates rising significantly in men over 60, 70, and 80. This suggests that the cumulative effect of hormonal changes and other factors over time leads to prostate enlargement.
3. Genetic Predisposition/Family History:
Men with a family history of BPH (especially a father or brother with the condition) are at a significantly higher risk of developing it themselves.
This suggests a genetic component, and studies have indicated that inherited forms of BPH may lead to larger prostate volumes and earlier onset of symptoms.
4. Other Contributing and Risk Factors:
Inflammation: Chronic inflammation within the prostate (sometimes related to chronic prostatitis) may play a role in promoting prostate cell growth.
Metabolic Syndrome and Obesity: There is growing evidence linking BPH to metabolic syndrome (a cluster of conditions including abdominal obesity, high blood pressure, insulin resistance, and abnormal cholesterol levels) and obesity.
Proposed mechanisms include increased systemic inflammation and altered hormone levels. Diabetes and Heart Disease: These conditions are also associated with an increased risk of BPH and lower urinary tract symptoms (LUTS).
Lifestyle Factors: While not direct causes, certain lifestyle factors may influence the risk or progression of BPH symptoms:
Lack of Physical Activity: A sedentary lifestyle has been linked to an increased risk.
Diet: Diets high in red or processed meat, saturated fats, and dairy products have been implicated, while some evidence suggests a protective effect from certain antioxidants (e.g., beta-carotene).
Alcohol and Caffeine: While not directly causing BPH, excessive intake can worsen urinary symptoms.
In summary, BPH is primarily an age-related condition driven by complex hormonal shifts, particularly the influence of DHT and the balance between estrogens and androgens.
Treatment for Benign Prostatic Hyperplasia (BPH) is highly individualized, depending on the severity of symptoms, the size of the prostate, the patient's overall health, and personal preferences.
Here's an overview of the common treatment approaches:
1. Watchful Waiting (Active Surveillance)
For men with mild symptoms that don't significantly impact their quality of life, a "watchful waiting" approach may be recommended.
Regular Monitoring: Periodic check-ups with a doctor to monitor symptoms, prostate size, and general health.
Lifestyle Modifications:
Fluid Management: Reducing fluid intake, especially before bedtime or going out.
Avoiding Irritants: Limiting caffeine, alcohol, and carbonated drinks, which can irritate the bladder.
Timed Voiding: Establishing a regular urination schedule and avoiding holding urine for too long.
Double Voiding: After urinating, waiting a few moments and trying to urinate again to ensure complete bladder emptying.
Avoiding Certain Medications: Over-the-counter cold and allergy medicines containing decongestants (e.g., pseudoephedrine, phenylephrine) or antihistamines (e.g., diphenhydramine) can worsen urinary symptoms by tightening muscles around the urethra.
Pelvic Floor Exercises: Strengthening pelvic floor muscles can help with bladder control.
Maintaining a Healthy Weight and Exercise: Obesity can worsen BPH symptoms.
2. Medications
Medications are often the first-line treatment for moderate to severe BPH symptoms.
Alpha-Blockers:
How they work: These drugs relax the smooth muscles in the prostate and bladder neck, making it easier for urine to flow.
They work relatively quickly, often within days or weeks. Examples: Tamsulosin (Flomax), alfuzosin (Uroxatral), doxazosin (Cardura), silodosin (Rapaflo), terazosin.
Side Effects: Can include dizziness, lightheadedness (due to blood pressure drop), retrograde ejaculation (semen goes into the bladder instead of out the penis), and nasal congestion.
5-Alpha Reductase Inhibitors (5-ARIs):
How they work: These medications shrink the prostate gland by blocking the production of dihydrotestosterone (DHT), a hormone involved in prostate growth.
They take longer to work (up to 6 months or more) and are most effective for men with larger prostates. Examples: Finasteride (Proscar), dutasteride (Avodart).
Side Effects: Can include sexual side effects like reduced libido, erectile dysfunction, and ejaculatory dysfunction.
Combination Therapy:
For men with moderate to severe symptoms and larger prostates, combining an alpha-blocker and a 5-ARI often provides better symptom relief and prevents disease progression more effectively than either drug alone.
Phosphodiesterase-5 (PDE5) Inhibitors:
How they work: Tadalafil (Cialis), commonly used for erectile dysfunction, has also been shown to improve BPH symptoms by relaxing smooth muscles in the bladder and prostate.
Side Effects: Can include headache, back pain, muscle aches, and flushing.
It's important to discuss potential interactions with other medications, especially nitrates.
Anticholinergics:
How they work: Sometimes used in combination with alpha-blockers, these drugs relax the bladder muscle, which can help with urgency and frequency if the bladder is overactive due to BPH.
Examples: Oxybutynin, tolterodine, solifenacin.
Side Effects: Can include dry mouth, constipation, and blurred vision. They are generally not used alone for primary BPH treatment.
3. Minimally Invasive Procedures (MIPs)
These procedures are less invasive than traditional surgery and are often performed on an outpatient basis or with a short hospital stay.
Transurethral Resection of the Prostate (TURP):
Considered the "gold standard" for surgical BPH treatment. A resectoscope (a thin, lighted tube with a cutting tool) is inserted through the urethra, and excess prostate tissue is removed piece by piece using an electrical loop or laser.
Benefits: Highly effective at improving urine flow and symptoms.
Side Effects: Can include retrograde ejaculation, bleeding, and, rarely, incontinence or erectile dysfunction.
Laser Therapies:
Various lasers are used to vaporize, cut, or enucleate (remove) obstructing prostate tissue.
Photoselective Vaporization of the Prostate (PVP, e.g., GreenLight™ Laser):
Uses a high-power laser to vaporize prostate tissue. Holmium Laser Enucleation of the Prostate (HoLEP):
Uses a laser to precisely remove the entire enlarged portion of the prostate, similar to open surgery but done through the urethra. This is very effective for large prostates. Thulium Laser Vapoenucleation/Vaporization of the Prostate (ThuLEP/ThuVP): Another laser option with similar benefits to HoLEP or PVP.
Benefits: Often less bleeding, shorter hospital stays, and quicker recovery compared to traditional TURP.
Prostatic Urethral Lift (PUL or UroLift System):
Small, permanent implants are used to hold the enlarged prostate tissue away from the urethra, widening the passage.
No cutting, heating, or removal of tissue is involved. Benefits: Generally preserves sexual function (no retrograde ejaculation), quick recovery. Suitable for men without a large median lobe.
Water Vapor Thermal Therapy (Rez?m):
Uses targeted bursts of sterile water vapor (steam) to destroy excess prostate tissue.
The treated tissue shrinks over time, opening the urethra. Benefits: Can be done in an office setting, typically preserves sexual function, and is suitable for various prostate sizes. Symptom improvement is gradual over a few weeks or months.
Prostate Artery Embolization (PAE):
An interventional radiologist blocks the blood supply to parts of the prostate using tiny particles, causing it to shrink.
